Abiopharma

News list

Director Gline Matthew 🔴 sold 289.8K shares of Roivant Sciences Ltd. (ROIV) at $29.16 ($8.4M) Transaction Date: Apr 16, 2026 | Filing ID: 000038

Full text

News bot April 20, 2026, 10:28 p.m.
🔍 Gline Matthew (Director)

Company: Roivant Sciences Ltd. (ROIV)

Report Date: 2026-04-16
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 289,774
Detailed Transactions and Holdings:
- Sold 289,774 shares of Common Shares at $29.16 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,736,116.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.98 to $29.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.